Haleos Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Unaudited financial results (Standalone ....
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Haleos Labs Ltd has informed the stock exchanges that its 96th Board Meeting is scheduled for Wednesday, February 11, 2026. The Board will consider and approve the unaudited financial results (both Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. A separate meeting of Independent Directors will also be held on the same day to evaluate the performance of the Board and Non-Independent Directors as required by SEBI regulations. The trading window for designated persons and their immediate relatives remains closed until February 15, 2026, which is standard practice ahead of results announcement.
This is a routine regulatory filing with no actual financial numbers disclosed yet. Investors should await the Q3FY26 results announcement on or after February 11, 2026, for any meaningful impact on the stock. The trading window closure is standard and does not signal anything unusual.